Targeting ERα Coregulator Networks to Overcome Endocrine Resistance in ER+ Breast Cancer
{{output}}
Breast cancer (BC) is the most commonly diagnosed tumor among women worldwide. Approximately 70% of cases are estrogen receptor-positive (ER+), whose growth is driven by estrogen signaling. Endocrine therapies targeting ER signaling are the common treatment fo... ...